Evidence map›Paper›PMID 29157266›Full record

ArticleJournal of experimental & clinical cancer research : CR2017

Doxorubicin combined with low intensity ultrasound suppresses the growth of oral squamous cell carcinoma in culture and in xenografts.

Haixia Fan, Haixia Li, Guanyao Liu, Wei Cong, Hong Zhao, Wenwu Cao, Jinhua Zheng

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Haixia FanDepartmentof Anatomy, Basic Medical Science College, Harbin Medical University, 194 Xuefu Road, Nangang District, Harbin, 150081, China.
Haixia LiDepartment of Forensic Medicine, Basic Medical Science College, Harbin Medical University, Harbin, 150081, China.
Guanyao LiuDepartment of Oral Pathology, Stomatological Hospital, Harbin Medical University, Harbin, 150001, China.
Wei CongDepartmentof Anatomy, Basic Medical Science College, Harbin Medical University, 194 Xuefu Road, Nangang District, Harbin, 150081, China.
Hong ZhaoDepartmentof Anatomy, Basic Medical Science College, Harbin Medical University, 194 Xuefu Road, Nangang District, Harbin, 150081, China.
Wenwu CaoCondensed Matter Science and Technology Institute, and Department of Physics, Harbin Institute of Technology, Harbin, 150080, China.
Jinhua ZhengDepartmentof Anatomy, Basic Medical Science College, Harbin Medical University, 194 Xuefu Road, Nangang District, Harbin, 150081, China. jhzheng@ems.hrbmu.edu.cn.
Harbin Medical University · CNJining Medical University · CNPennsylvania State University · US

Funding

National Natural Science Foundation of China No. 81272503National Natural Science Foundation of China No.81502644
6 · The paper itself

Abstract

backgroundOral squamous cell carcinoma (OSCC) invades surrounding tissues by upregulating matrix metalloproteinases (MMPs) -2 and -9, which causes over-expression of the Hedgehog signaling proteins Shh and Gli-1 and degradation of the extracellular matrix, thereby creating a "highway" for tumor invasion. We explored the potential of low intensity ultrasound (LIUS) and doxorubicin (DOX) to inhibit the formation of this "highway".

methodsMTT assays were used to examine OSCC cell viability after exposure to LIUS and DOX. The cell morphological changes and ultrastructure were detected by scanning electron microscopy and transmission electron microscopy. Endogenous autophagy-associated proteins were analyzed by immunofluorescent staining and western blotting. Cell migration and invasion abilities were evaluated by Transwell assays. Collagen fiber changes were evaluated by Masson's trichrome staining. Invasion-associated proteins were analyzed by immunohistochemistry and western blotting.

resultsLIUS of 1 W/cm

conclusionsOur findings suggest that effective low dosages of DOX in combination with LIUS can inhibit cell proliferation, migration and invasion, which might be through MMP-2/9 production mediated by the Hedgehog signaling pathway.

Indexed as

AnimalsCarcinoma, Squamous CellCell Line, TumorCell MovementCell ProliferationCell SurvivalDoxorubicinGene Expression Regulation, NeoplasticHedgehog ProteinsHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9MiceMouth NeoplasmsPrognosisSignal TransductionDoxorubicinGLI1 protein, humanHedgehog ProteinsMatrix Metalloproteinase 2Matrix Metalloproteinase 9MMP2 protein, humanMMP9 protein, humanSHH protein, humanZinc Finger Protein GLI1DoxorubicinHedgehog signaling pathwayMMP-2/9Oral squamous cancer cellsUltrasound

Identifiers

PMID29157266
PMCPMC5696881
OpenAlexW2768849917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.